Science Explorer Interactive view Map
Company · Seoul · South Korea

Boryung Pharma (South Korea)

boryung.co.kr/eng/index.doROR OpenAlex
Research works
50
▲ 70% vs 2013–17
Citations
560
11.1 per fractional work
Top-10% rate
20.3%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Boryung Pharma (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.71× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.76× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 2.69× its world share, 0 worksImmunology and Micro…Neuroscience: 1.25× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.76× its world share, 0 worksPharmacology, Toxico…Chemistry: 2.59× its world share, 0 worksChemistryComputer Science: 0.52× its world share, 0 worksComputer ScienceEngineering: 0.85× its world share, 1 worksEngineeringMaterials Science: 0.17× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.91× its world share, 0 worksPhysics and AstronomyMedicine: 2.03× its world share, 3 worksMedicineNursing: 2.07× its world share, 0 worksNursingArts and Humanities: 2.11× its world share, 0 worksArts and HumanitiesSocial Sciences: 0.48× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.8×. Every wedge is a field page.

Which keywords describe research at Boryung Pharma (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Hypertension, Cardiovascular Events, Cardiovascular Disease, Inflammation, Cancer Therapy, Diabetes Mellitus, Global Burden and Medicinal Chemistry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Hypertension5▲ 27×6 topics
  2. Inflammation4▲ 3.1×13 topics
  3. Epidemiology4▲ 1.72×19 topics
  4. Cardiovascular Disease3▲ 6.1×8 topics
  5. Cardiovascular Events3▲ 38×2 topics
  6. Cancer2▲ 3.2×11 topics
  7. Cancer Therapy2▲ 6.9×9 topics
  8. Diabetes Mellitus2▲ 18×3 topics
  9. Global Burden2▲ 7.4×3 topics
  10. Metabolism2▲ 6.1×7 topics
  11. Medicinal Chemistry2▲ 10×7 topics
  12. Risk Factors2▲ 3.4×2 topics
  13. Biopharmaceuticals2▲ 50×3 topics
  14. Chemotherapy2▲ 4.8×3 topics
  15. Metabolic Syndrome2▲ 4.0×3 topics
  16. Aldosterone2▲ 70×1 topic
  17. Blood Pressure2▲ 45×2 topics
  18. Clinical Guidelines2▲ 10×2 topics
  19. Primary Aldosteronism2▲ 70×1 topic
  20. Antihypertensive Drugs2▲ 55×1 topic
  21. Pharmacokinetics2▲ 11×4 topics
  22. Renal Denervation2▲ 55×1 topic
  23. Cell Signaling1▲ 8.0×4 topics
  24. Cytochrome P4501▲ 38×2 topics
  25. Diabetes1▲ 5.6×3 topics
  26. Pathogenesis1▲ 4.8×8 topics
  27. Pharmacology1▲ 8.2×4 topics
  28. Recombinant Proteins1▲ 52×2 topics
  29. Rituximab1▲ 18×2 topics
  30. Glycosylation1▲ 12×3 topics
  31. Monoclonal Antibodies1▲ 18×3 topics
  32. Prognostic Factors1▲ 5.8×3 topics
  33. Transcriptional Regulation1▲ 11×4 topics
  34. Vaccine1▲ 6.3×7 topics
  35. Anticancer Agents1▲ 9.4×5 topics
  36. Drug Discovery1▲ 6.1×2 topics
  37. Molecular Mechanisms1▲ 13×2 topics
  38. Medical Imaging1▲ 8.1×3 topics
  39. Mutation1▲ 14×3 topics
  40. Stromal Cells1▲ 24×2 topics

Which research topics does Boryung Pharma (South Korea) publish most on?

By volume in 2022–2025: Lung Cancer Diagnosis and Treatment, Radiomics and Machine Learning in Medical Imaging, Historical and Cultural Studies of Poland and Language and Culture.

Lung Cancer Diagnosis and Treatment: 1 fractional worksRadiomics and Machine Learning in Medical Imaging: 1 fractional worksHistorical and Cultural …0Historical and Cultural Studies of Poland: 0 fractional worksLanguage and Culture0Language and Culture: 0 fractional worksInnovative concrete reinforcement materials: 0 fractional worksConcrete and Cement Materials Research: 0 fractional worksAI in cancer detection0AI in cancer detection: 0 fractional worksHydrogels: synthesis, properties, applications: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksCatalytic Cross-Coupling Reactions: 0 fractional works
Pulmonary and Respiratory MedicineRadiology, Nuclear Medicine and ImagingHistoryLinguistics and Language5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  2. 2 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Historical and Cultural Studies of Poland History 0 works
  4. 4 Language and Culture Linguistics and Language 0 works
  5. 5 Innovative concrete reinforcement materials Civil and Structural Engineering 0 works
  6. 6 Concrete and Cement Materials Research Civil and Structural Engineering 0 works
  7. 7 AI in cancer detection Artificial Intelligence 0 works
  8. 8 Hydrogels: synthesis, properties, applications Molecular Medicine 0 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 0 works
  10. 10 Catalytic Cross-Coupling Reactions Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.4%not open64.6%

World: 28% of research is openly available.

with international co-authors18.3%domestic only81.7%

World: 19% is written across borders.

How has Boryung Pharma (South Korea)'s research output changed?

Output in 2018–2022 was 70% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seoul

All research institutions in Seoul

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.